Immuno-oncology Research

Application note

ACD evaluated the performance of the RNAscope assay in the detection of a wide range of important immuno-oncology markers, including 12 immune checkpoint markers (i.e., PD-L1, CTLA-4, IDO1), 14 immune cell markers (i.e., CD3, CD4, CD8) and 24 immune function markers (i.e., IFNG,TGFB, IL6, CXCL10) in multiple FFPE human tumor samples.

Application Note

Application note "Detection of immune cell checkpoint and functional markers in the tumor microenvironment by the RNA in situ hybridization RNAscope assay'

Appendix

Appendix "Detection of immune cell checkpoint and functional markers in the tumor microenvironment by the RNA in situ hybridization RNAscope assay"

X
Contact Us

Complete one of the three forms below and we will get back to you.

For Quote Requests, please provide more details in the Contact Sales form below

Content for comparison